Answers are grounded in this paper and cite their sources.
Chronic disease burden is a major driver of morbidity, mortality, and health care expenditures. Dual-eligible Medicare beneficiaries have a greater burden of chronic disease and higher health care utilization than Medicare-only beneficiaries. Factors associated with clinically recognized disease progression are not well understood. To address this gap, a retrospective cohort study of 368 Medicare Advantage beneficiaries aged 65 years and older receiving annual care in two primary care practices from 2018 through 2022 was conducted. Disease progression was determined from detailed electronic medical record review and was based on clinical assessments documented by treating providers. Disease progression occurred more frequently among dual-eligible than non-dual-eligible beneficiaries (45.3% vs. 33.3%). Dual-eligible beneficiaries also had a greater baseline chronic disease burden (mean 4.42 vs. 3.37 chronic diseases). The percentage of patients that progressed increased with increasing chronic disease burden, and each additional chronic disease was associated with higher odds of progression (adjusted odds ratio 1.58, 95% confidence interval [1.33-1.88]). After adjustment for chronic disease burden and demographic factors, dual-eligible status was not independently associated with disease progression. Beneficiaries with comparable chronic disease burden had similar probabilities of progression regardless of dual-eligible status. These findings show that the greater likelihood of disease progression observed among dual-eligible Medicare Advantage beneficiaries that are continuously followed in a clinical practice is largely explained by chronic disease burden. These findings reinforce the role of continuous care for dual-eligible patients and the importance of prevention and control of chronic disease management.
No takes yet. Share an insight, caveat, or question.
Michael A. Kolber (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: